UK markets open in 5 hours 44 minutes
NIKKEI 225
38,560.62 -359.64 (-0.92%) HANG SENG
19,376.53 0.00 (0.00%) CRUDE OIL
79.22 -0.01 (-0.01%) GOLD FUTURES
2,382.20 -3.30 (-0.14%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,584.03 -632.89 (-1.21%)
Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 145.07M |
| Enterprise value | 248.07M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.00 |
| Price/book (mrq) | 63.84 |
| Enterprise value/revenue | 1.96 |
| Enterprise value/EBITDA | -2.82 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.14 |
| 52-week change 3 | -80.12% |
| S&P500 52-week change 3 | 26.44% |
| 52-week high 3 | 6.2600 |
| 52-week low 3 | 0.5400 |
| 50-day moving average 3 | 0.8217 |
| 200-day moving average 3 | 1.6152 |
Share statistics
| Avg vol (3-month) 3 | 5.04M |
| Avg vol (10-day) 3 | 6.74M |
| Shares outstanding 5 | 151.45M |
| Implied shares outstanding 6 | 163.15M |
| Float 8 | 119.55M |
| % held by insiders 1 | 5.66% |
| % held by institutions 1 | 56.82% |
| Shares short (30 Apr 2024) 4 | 21.46M |
| Short ratio (30 Apr 2024) 4 | 4.24 |
| Short % of float (30 Apr 2024) 4 | 19.91% |
| Short % of shares outstanding (30 Apr 2024) 4 | 14.21% |
| Shares short (prior month 28 Mar 2024) 4 | 18.8M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -65.18% |
| Operating margin (ttm) | -60.70% |
Management effectiveness
| Return on assets (ttm) | -15.74% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 126.85M |
| Revenue per share (ttm) | 0.95 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -70.6M |
| Net income avi to common (ttm) | -82.68M |
| Diluted EPS (ttm) | -0.5900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 111.18M |
| Total cash per share (mrq) | 0.73 |
| Total debt (mrq) | 214.18M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.68 |
| Book value per share (mrq) | -0.39 |
Cash flow statement
| Operating cash flow (ttm) | -76.01M |
| Levered free cash flow (ttm) | -25.42M |
© 2024 Yahoo. All rights reserved.